Cargando…
Comprehensive in vitro analysis evaluating the variable drug–drug interaction risk of rifampicin compared to rifabutin
Compared to rifampicin (600 mg/day), standard doses of rifabutin (300 mg/day) have a lower risk of drug–drug interactions due to induction of cytochrome P450 3A4 (CYP3A4) or P-glycoprotein (Pgp/ABCB1) mediated by the pregnane X receptor (PXR). However, clinical comparisons with equal rifamycin doses...
Autores principales: | Nilles, Julie, Weiss, Johanna, Sauter, Max, Haefeli, Walter E., Ruez, Stephanie, Theile, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322781/ https://www.ncbi.nlm.nih.gov/pubmed/37285043 http://dx.doi.org/10.1007/s00204-023-03531-2 |
Ejemplares similares
-
How to avoid misinterpretation of dual reporter gene assay data affected by cell damage
por: Nilles, Julie, et al.
Publicado: (2022) -
Metabolomics-based strategy to assess drug hepatotoxicity and uncover the mechanisms of hepatotoxicity involved
por: Martínez-Sena, Teresa, et al.
Publicado: (2023) -
Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury
por: Tolosa, Laia, et al.
Publicado: (2017) -
Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approach
por: Vatakuti, Suresh, et al.
Publicado: (2016) -
Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity
por: Herpers, Bram, et al.
Publicado: (2015)